Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 85
  • 0 comments

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text

HIKMA

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 83
  • 0 comments

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text

NEXUS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 70
  • 0 comments

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text

DR REDDYS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 80
  • 0 comments

FDA approve PALIPERIDONE

Comment Full text

ALEMBIC

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 80
  • 0 comments

FDA approve TADALAFIL

Comment Full text

WATSON LABS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 87
  • 0 comments

FDA approve CLORAZEPATE DIPOTASSIUM

Comment Full text

WATSON LABS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 74
  • 0 comments

FDA approve CLORAZEPATE DIPOTASSIUM

Comment Full text

WATSON LABS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 83
  • 0 comments

FDA approve CLORAZEPATE DIPOTASSIUM

Comment Full text

BARR

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 74
  • 0 comments

FDA approve GALANTAMINE HYDROBROMIDE

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 79
  • 0 comments

FDA approve ANASTROZOLE

Comment Full text
  • Previous
  • 233
  • 234
  • 235
  • 236
  • 237
  • Next

Search

News categories

  • Technical Exchange News(11390)
  • Event(3033)
  • SEC News(208855)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(135505)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin